IGFBP-2 was observed in both adjacent benign tissue as well as in the cancer region and showed no significant difference between them in the smaller cohort (p = 0.274), however in the larger PrEvENT cohort, IGFBP-2 expression was significantly increased in cancer compared to benign tissue (p = 0.001). Here, IGFBP2 is linked to cancer.